{"created":"2014-11-21T19:01:16+00:00","modified":"2014-11-21T22:12:14+00:00","valid":{"from":"2014-11-21T22:12:14+00:00","to":"3014-11-21T22:12:14+00:00"},"hreflang":"en","title":"FDA Approves Slow-Release Painkiller","published":"2014-11-21T22:12:00+00:00","teaser":"Hysingla is designed to prevent people from abusing it as a narcotic. But the FDA says abuse and overdose is still possible.","itags":["npr_api","365732080"],"guid":"275a59eb-5bc2-4417-b69c-049f4c1dc86d","contentencoded":"<p>The FDA has approved a new opioid painkiller that releases over a 24-hour period, and is designed to reduce abuse by people chewing or smashing it into a powder for injection. However, the agency admits that abuse and overdose of the drug Hysingla is still possible.</p><p><strong>Michael Regan </strong>of Bloomberg News spoke to <em><a href=\"http://hereandnow.wbur.org/\" target=\"_blank\">Here & Now&#8217;</a></em>s Jeremy Hobson about the new drug.</p><h4>Guest</h4><ul><li><a href=\"http://www.businessweek.com/authors/1838-michael-p-regan\" target=\"_blank\"><strong>Michael Regan</strong></a>, editor for Bloomberg News. He tweets <a class=\"ProfileHeaderCard-screennameLink u-linkComplex js-nav\" href=\"https://twitter.com/Reganonymous\">@<span class=\"u-linkComplex-target\">Reganonymous</span></a>.</li></ul>  <div class=\"fullattribution\">Copyright 2014 NPR. To see more, visit <a href=\"http://www.npr.org/\">http://www.npr.org/</a>.<img src=\"http://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=FDA+Approves+Slow-Release+Painkiller&utme=8(APIKey)9(MDAyOTcwNDAwMDEyODgyMDkwMTgwNzY3YQ001)\"/></div>","audio":[{"meta":{"duration":"242"},"type":"audio/m3u","href":"http://api.npr.org/m3u/1365732083-08c85d.m3u?orgId=1&ft=3&f=365732080"}]}